| MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non–Small Cell Lung Carcinoma with Poor PrognosisMET DNA Alterations in NSCLC JH Tong, SF Yeung, AWH Chan, LY Chung, SL Chau, RWM Lung, ... Clinical Cancer Research 22 (12), 3048-3056, 2016 | 481 | 2016 |
| Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant KF To, JHM Tong, KSF Yeung, RWM Lung, PPY Law, SL Chau, W Kang, ... Journal of Thoracic Oncology 8 (7), 883-891, 2013 | 83 | 2013 |
| Profiling of oncogenic driver events in lung adenocarcinoma revealed MET mutation as independent prognostic factor SF Yeung, JHM Tong, PPW Law, LY Chung, RWM Lung, CYK Tong, ... Journal of Thoracic Oncology 10 (9), 1292-1300, 2015 | 70 | 2015 |
| TEC kinase stabilizes PLK4 to promote liver cancer metastasis SF Yeung, Y Zhou, W Zou, WL Chan, YP Ching Cancer Letters 524, 70-81, 2022 | 13 | 2022 |
| The role of centrosome amplification in HCC SF Yeung, YP Ching Cancer Research 78 (13_Supplement), 453-453, 2018 | | 2018 |
| The role of centrosome over-duplication in liver cancer YP Ching, SHV Chan, SF Yeung BIT's Annual Congress of International Drug Discovery Science and Technology, 2017 | | 2017 |
